Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension. [Phase 3]
Phase 3 trial evaluating a fixed-dose triple combination of amlodipine, bisoprolol fumarate, and perindopril arginine versus monotherapy at …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension (RICBP-EH) [NA]
A completed clinical trial evaluating the efficacy and safety of remote ischemic conditioning in essential hypertension. The study is regist…
-
EMA approval · 2025-05-13EMA Authorised: Actelsar HCT (telmisartan;hydrochlorothiazide) — Actavis Group PTC ehf
The European Medicines Agency has authorised Actelsar HCT, a fixed-dose combination of telmisartan and hydrochlorothiazide, for essential hy…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions [Phase 1]
A Phase 1 study evaluating the pharmacokinetics and safety of BR1015 alone and in combination with BR1015-1 and BR1015-2 under fasting condi…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions [Phase 1]
This Phase 1 study evaluated the pharmacokinetics and safety of BR1015 alone and in combination with BR1015-3 and BR1015-2 under fed conditi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed Conditions [Phase 1]
Phase 1 pharmacokinetics and safety study evaluating BR1015 alone and in combination with BR1015-1 and BR1015-2 in healthy volunteers under …
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions [Phase 1]
This Phase 1 trial evaluated the pharmacokinetics and safety of BR1015 alone and in combination with BR1015-3 and BR1015-2 under fasting con…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-223 [Phase 3]
The Phase 3 trial evaluating AD-223 for essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers [Phase 1]
Phase 1 study assessing pharmacokinetics, pharmacodynamics, and safety of BR1400-1, BR1400-2, and BR1400-3 in healthy adult volunteers; the …
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension [Phase 3]
A Phase 3 trial comparing losartan/chlorthalidone to losartan/hydrochlorothiazide for essential hypertension has completed, with results on …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents [Phase 3]
Phase III clinical study of valsartan oral solution for treating essential hypertension in children and adolescents is currently enrolling b…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System [NA]
An ongoing clinical trial in China and Argentina evaluating a mobile app-based telecare system to improve hypertension control.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension [Phase 3]
A Phase 3 study evaluating the efficacy and safety of HCP1803 compared with RLD2001-1 in essential hypertension has completed.
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Efficacy and Safety of SPC1001 in Patients With Essential Hypertension [Phase 2]
This clinical trial update reports a Phase 2 study assessing the efficacy and safety of SPC1001 in adults with essential hypertension, curre…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of co-administration of AD-227A and AD-227B for essential hypertension and is…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-224 [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of AD-224 for essential hypertension is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.
A registry study exploring primary and secondary hypertension phenotypes, complications, and opportunities for personalized treatment, spons…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients [Phase 3]
Phase III trial evaluating the efficacy and safety of SYH9056 (valsartan/levamlodipine) tablets in patients with mild-to-moderate essential …
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy [Phase 3]
A Phase 3 trial evaluating BR1015 in combination therapy for essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers [Phase 1]
Phase 1 study assessing pharmacokinetics and safety of BR1019 alone and in combination with BR1019-3 and BR1019-2 in healthy volunteers; the…
-
CLINICAL_TRIALS other · 2024-12-06Clinical Trial Update: QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension [Phase 3]
Phase 3 trial update for QR12000 compound tablets in patients with essential hypertension; the study is currently not recruiting.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension [Phase 3]
Phase 3 trial update for a fixed-dose combination of an angiotensin receptor blocker and a thiazide diuretic in essential hypertension; the …
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
A clinical trial evaluating the efficacy and safety of TEL/AML/CTD in elderly patients with essential hypertension, sponsored by Yuhan Corpo…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Positive Care Effect of the Digital Health Assistant ADELE Blood Pressure for Hypertension Patients [NA]
A completed clinical trial evaluating the digital health assistant ADELE Blood Pressure for hypertension patients reports positive care effe…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of BR1017A and BR1017B in essential hypertension with primary hypercholesterolem…